A
4.22
-0.03 (-0.71%)
| Penutupan Terdahulu | 4.25 |
| Jumlah Dagangan | 881,632 |
| Harga / Jualan (P/S) | 10.34 |
| Harga / Buku (P/B) | 1.90 |
| Julat 52 Minggu |
| EPS Cair (TTM) | -0.630 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 57.92% |
| Nisbah Semasa (MRQ) | 4.90 |
| Aliran Tunai Operasi (OCF TTM) | -59.88 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -39.71 M |
| Pulangan Atas Aset (ROA TTM) | -49.95% |
| Pulangan Atas Ekuiti (ROE TTM) | -271.78% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Abeona Therapeutics Inc. | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 2.1 |
| Purata Bergerak Teknikal | 1.5 |
| Osilator Teknikal | -2.5 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | -0.5 |
| Persekitaran Makro | -1.3 |
| AI Insight | NA |
| AI Technical | NA |
| Purata | -0.08 |
|
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 5.84% |
| % Dimiliki oleh Institusi | 63.35% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Onedigital Investment Advisors Llc | 30 Jun 2026 | 1,653,024 |
| Nan Fung Trinity (Hk) Ltd | 30 Jun 2026 | 956,770 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |